Yayın:
Comment on: “clinical relevance of insulin-like growth factor-1 to cardiovascular risk markers”

dc.contributor.authorÖzge Turgay Yıldırım
dc.contributor.authorYILDIRIM, SELİM
dc.contributor.authorSelim Yıldırım
dc.contributor.orcid0000-0002-6731-4958
dc.contributor.orcid0000-0002-7900-6813
dc.date.accessioned2025-11-13T22:36:01Z
dc.date.issued2019-12-04
dc.identifier.doihttps://doi.org/10.1080/13685538.2019.1699046
dc.identifier.endpage7
dc.identifier.issn1368-5538
dc.identifier.issue1
dc.identifier.openalexW2992513419
dc.identifier.startpage7
dc.identifier.urihttps://hdl.handle.net/11421/14692
dc.identifier.urihttps://doi.org/10.1080/13685538.2019.1699046
dc.identifier.volume23
dc.language.isoen
dc.relation.ispartofThe Aging Male
dc.rightsrestrictedAccess
dc.subjectRelevance (law)
dc.subjectClinical significance
dc.subjectInsulin-like growth factor
dc.subjectRisk factor
dc.subjectInternal medicine
dc.subjectMedicine
dc.subjectInsulin
dc.subjectGrowth factor
dc.subjectPolitical science
dc.subject.sdg2
dc.titleComment on: “clinical relevance of insulin-like growth factor-1 to cardiovascular risk markers”
dc.typeletter
dspace.entity.typePublication
local.authorid.openalexA5048433004

Dosyalar

Koleksiyonlar